Intracellular PD Modelling (PDi) for the Prediction of Clinical Activity of Increased Rifampicin Dosing

DOI: 10.3390/pharmaceutics11060278

Keywords: pharmacokinetic/pharmacodynamic modelling, rifampicin, high dose, tuberculosis, infectious diseases, Mycobacterium tuberculosis

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text